Extent of MGMT promoter methylation modifies the effect of temozolomide on overall survival in patients with glioblastoma: a regional cohort study.
Michael Tin-Chung PoonShivank KeniVineeth VimalanChak IpColin SmithSara ErridgeChristopher J WeirPaul M BrennanPublished in: Neuro-oncology advances (2021)
methylation may provide additional prognostic value. This is important when assessing clinical and research therapies.